N-PORT filing recap · June 2024
What did Meridian Contrarian Fund buy in June 2024?
Reported stock-position changes between this filing and the previous one. These are Meridian Contrarian Fund's own holdings, not the firm's.
Stock value
$527.05M
Positions
63
Estimated turnover
25.7%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Period in review
Meridian Contrarian Fund opened new positions in Evergy, Integra Lifesciences Holdings, Radius Recycling, and Springworks Therapeutics. It exited Cerence, Clorox, Custom Truck One Source, Inhibrx Biosciences, L3Harris Technologies, Molson Coors Beverage, Paragon 28, and Spectrum Brands Holdings. Among existing holdings, the fund sharply increased its stakes in Seaboard Corporation and U-Haul Holding Company, substantially added to Aritzia, Constellium, Regal Rexnord, Blackberry, and Quidelortho, and substantially trimmed Liveramp Holdings, Okta, and National Vision Holdings.